Carcinoma de células escamosas laríngeas
Vista determinista de la entidad fuente YAML. La autoridad clínica sigue con los ID de fuente citados y estado de firma del revisor.
| ID | DIS-LARYNGEAL |
|---|---|
| Tipo | Enfermedad |
| Aliaces | Cáncer de la laringeCáncer glóticoCCE laríngeaCáncer de laringeCáncer subglóticoCáncer supraglóticoПлоскоклітинна карцинома гортані |
| Situación | reviewed 2026-05-18 | pending_clinical_signoff |
| Enfermedades | Ninguna declarada |
| Fuentes | SRC-IARC-MONO-100B-2012 SRC-NCCN-HNSCC-2025 |
Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.
| icd_o_3_morphology | 8070/3 |
|---|---|
| icd_o_3_topography | ["C32"] |
| icd_10 | C32 |
| who_classification | WHO Head and Neck Tumours 5th ed (2022): Laryngeal squamous cell carcinoma (glottic / supraglottic / subglottic subsites) |
Notas
Three subsites with distinct biology and treatment patterns. Early glottic (T1-T2N0): radiation OR transoral laser microsurgery (TLM) — both ~90% local control with voice preservation as key endpoint. Locally advanced: larynx-preservation chemoradiation (cisplatin + RT) per RTOG 91-11 / VA-trial paradigm vs total laryngectomy + postoperative RT — patient preference / fitness drives choice. Recurrent / metastatic: pembrolizumab ± chemo per KEYNOTE-048 (same framework as broader HNSCC). Smoking cessation surveillance dominates prevention narrative.
Utilizado por
Algoritmos
ALGO-LARYNGEAL-1L- ALGO-LARYNGEAL-1L
Indicación
IND-LARYNGEAL-EARLY-GLOTTIC-1L-RT- IND-LARYNGEAL-EARLY-GLOTTIC-1L-RTIND-LARYNGEAL-EARLY-GLOTTIC-1L-TLM- IND-LARYNGEAL-EARLY-GLOTTIC-1L-TLMIND-LARYNGEAL-LA-1L-CRT- IND-LARYNGEAL-LA-1L-CRTIND-LARYNGEAL-LA-1L-TOTAL-LARYNGECTOMY- IND-LARYNGEAL-LA-1L-TOTAL-LARYNGECTOMYIND-LARYNGEAL-RM-1L-EXTREME- IND-LARYNGEAL-RM-1L-EXTREMEIND-LARYNGEAL-RM-1L-PEMBRO-CHEMO- IND-LARYNGEAL-RM-1L-PEMBRO-CHEMOIND-LARYNGEAL-RM-1L-PEMBRO-MONO-CPS-HIGH- IND-LARYNGEAL-RM-1L-PEMBRO-MONO-CPS-HIGH
Procedimientos
SUR-LARYNGEAL-TLM- Microcirugía láser transoral (TLM) para carcinoma glótico tempranoSUR-LARYNGEAL-TOTAL-LARYNGECTOMY- Laringectomía total
Señal de alerta
RF-LARYNGEAL-POOR-PRESERVATION-CANDIDACY- Feature precluding larynx-preservation chemoradiation (RTOG 91-11 concurrent cisplatin +...
Fuentes
SRC-KEYNOTE-048-BURTNESS-2019- Pembrolizumab solo o con quimioterapia versus cetuximab con quimioterapia para...SRC-RTOG-9111-FORASTIERE-2003- Quimioterapia y radioterapia concomitantes para la preservación de órganos en laringe...